Table 1.
Cohort creation and distribution of follow-up time
| Criterion or variable | Daily home HD | Home PD |
|---|---|---|
| Patients age ≥18 years, n | 4509 | 208,086 |
| Exclusions, n (%) | ||
| Not in the time windowa | 1067 (23.7) | 119,974 (57.7) |
| Nonindependent living | 166 (3.7) | 4355 (2.1) |
| Missing race | 0 (0) | 47 (0) |
| Missing comorbidity | 0 (0) | 8 (0) |
| Missing weight | 55 (1.2) | 6910 (3.3) |
| Albumin <1.0 or Hgb <5 | 25 (0.6) | 754 (0.4) |
| Prior transplants >2 | 3 (0.1) | 49 (0) |
| Follow-up <30 days | 51 (1.1) | 1067 (0.5) |
| Total excluded | 1367 (30.3) | 133,164 (64.0) |
| Eligible, n (%) | 3142 (69.7) | 74,922 (36.0) |
| Matched,b n (%) | 2668 (80.0) | 2668 (3.6) |
| Follow-up time (years) | ||
| Mean (SD) | 1.9 (1.3) | 2.0 (1.4) |
| Median (IQR) | 1.7 (0.8–2.8) | 1.7 (0.9–2.9) |
| Range | 0.1–6.5 | 0.1–7.2 |
aThe time window was defined as having started renal replacement therapy after 1995 and having started PD or daily HD between 2004 and 2011. Patients missing one or more of the following comorbidities were excluded: cancer, hypertension, congestive heart failure, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, and diabetes
bThe percentage matched was calculated as the proportion of eligible patients that were matched